Humana (NYSE:HUM) reported Q2 EPS of $8.67, $1.01 better than the analyst estimate of $7.66. Revenue for the quarter came in at $23.66 billion versus the consensus estimate of $23.45 billion.
GUIDANCE:
Humana sees FY2022 EPS of $24.75, versus the consensus of $24.63.